GOBIOM Biomarker

Hyderabad, India Founded: 2008 • Age: 18 yrs
Provides comprehensive solutions for biomarker database management and analysis.
Annual revenue $175.9M Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About GOBIOM Biomarker

GOBIOM Biomarker is a company based in Hyderabad (India) founded in 2008. It operates as a B2B. GOBIOM Biomarker operates in a competitive market with competitors including Metabolon, Maze Therapeutics, Alector, Seer and Tango Therapeutics, among others.

  • Headquarter Hyderabad, India
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $175.87 M (USD)
    0
    as on Mar 31, 2021
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of GOBIOM Biomarker

Premium access

Detailed funding history for GOBIOM Biomarker

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by GOBIOM Biomarker

Investments
Premium access

Investment portfolio details for GOBIOM Biomarker

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - GOBIOM Biomarker

Premium access

Detailed financials for GOBIOM Biomarker

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Gobiom Biomarker Comparisons

GOBIOM Biomarker Primary company
Description
Provides comprehensive solutions for biomarker database mana...
Location
Hyderabad, India
Founded Year
2008
Annual Revenue
$175.87 M (USD)
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for GOBIOM Biomarker

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of GOBIOM Biomarker

GOBIOM Biomarker operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Metabolon, Maze Therapeutics, Alector, Seer and Tango Therapeutics, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Solutions for biomarker discovery and diagnostic testing are provided.
Locked Locked Locked
Genetic biomarkers are developed for neurological, metabolic, and renal diseases.
Locked Locked Locked
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed.
Locked Locked Locked
Proteomics platform developed for early cancer and neurological disease detection.
Locked Locked Locked
Novel cancer drugs are developed using synthetic lethality screening.
Locked Locked Locked
AI-based data-mining tools for scientific evidence discovery are provided.
Premium access

Detailed competitors of GOBIOM Biomarker

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Gobiom Biomarker

Premium access

Complete news archive for GOBIOM Biomarker

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about GOBIOM Biomarker

GOBIOM Biomarker was founded in 2008.

GOBIOM Biomarker is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Annual revenue of GOBIOM Biomarker is $175.87M as on Mar 31, 2021.

GOBIOM Biomarker, established in 2008, excels in providing healthcare solutions, advancing biotech innovations, data services, and biomarker databases. Provides comprehensive solutions for biomarker database management and analysis. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.

GOBIOM Biomarker's top competitors include Alector, Lexicon Pharmaceuticals and Maze Therapeutics.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available